Tag: CD19 and BCMA Targets

Home / CD19 and BCMA Targets

Categories

Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Experience from China

 CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy has changed the course of treatment for numerous hematologic malignancies like leukemia, lymphoma, and multiple myeloma. China is at ...
cd19-and-bcma-targets

Scan the code